Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Forest Laboratories Inc.
Current Parent Company: AbbVie
Penalty: $10,350,000
Year: 2014
Date: September 8, 2014
Offense Group: consumer-protection-related offenses
Primary Offense: consumer protection violation
Secondary Offense: off-label or unapproved promotion of medical products
Violation Description: Forest Laboratories agreed to pay up to $10.35 million to settle litigation alleging it misled parents into purchasing Celexa and Lexapro for their children even though the antidepressants were approved only for adults.
Level of Government: federal
Action Type: private litigation
Court: District of Massachusetts
Civil or Criminal Case: civil
Case ID: 1:09-md-02067
Case Name: In Re: Celexa and Lexapro Marketing and Sales Practices Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: Illinois
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.